|
    ILMN U.S.: Nasdaq

    Illumina Inc.

    Watchlist
    NEW
    Set a price target alert
    ILMNUS
    After Hours
    Last Updated: Nov 10, 2023 7:59 p.m. EST Delayed quote

    $ 98.90

    0.53 0.54%
    After Hours Volume: 71.21K
    Close Chg Chg %
    $98.37 -8.61 -8.05%
    Advanced Charting
    Volume: 9.08M 65 Day Avg: 1.79M
    507% vs Avg
    89.00 Day Range 98.56
    89.00 52 Week Range 243.09

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ILMN Overview

    Key Data

    • Open $94.02
    • Day Range 89.00 - 98.56
    • 52 Week Range 89.00 - 243.09
    • Market Cap $15.57B
    • Shares Outstanding 158.3M
    • Public Float 157.59M
    • Beta 1.10
    • Rev. per Employee $388.26K
    • P/E Ratio N/A
    • EPS -$7.12
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest 5.18M 10/31/23
    • % of Float Shorted 3.28%
    • Average Volume 1.79M

    Performance

    5 Day
    • -15.87%
    1 Month
    • -23.81%
    3 Month
    • -45.50%
    YTD
    • -51.35%
    1 Year
    • -59.48%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 22 Full Ratings

    Recent News

    Read full story

    Illumina Inc. stock underperforms Friday when compared to competitors

    Read full story

    These Stocks Moved the Most Today: Plug Power, Trade Desk, Illumina, Doximity, Groupon, Hologic, and More

    Illumina’s stock on track for lowest close in 10 years after cutting guidance

    Read full story

    Illumina Stock Is the Worst Performer in the S&P 500. Grail Isn’t the Only Issue.

    Illumina Shares Drop on Forecast for 2023 Sales Decline, Wider Loss

    Stocks to Watch: Doximity, Illumina, Groupon

    Illumina shares fall as company cuts forecasts

    Read full story

    Illumina Inc. stock falls Thursday, underperforms market

    Illumina Expects Sales to Decline, Projects Wider Loss For Year

    Illumina 3Q Loss Narrows as Goodwill Charges Fall

    Read full story

    Illumina Inc. stock falls Wednesday, underperforms market

    Read full story

    Illumina Inc. stock outperforms competitors on strong trading day

    Read full story

    Illumina Inc. stock falls Monday, underperforms market

    Illumina Gets European Commission Order to Divest Grail

    Illumina responds to EC Grail divestiture order

    Illumina Ordered by EU to Unwind $7.1 Bln Grail Acquisition -- WSJ

    Illumina names Agilent executive as new CEO

    At Illumina, new leadership could fuel turnaround, analysts say

    Read full story

    Illumina Slashes Guidance Amid ‘Cautious’ Consumer. What Wall Street Thinks.

    Illumina stock falls, as ‘cautious consumer backdrop’ tempers outlook

    Illumina (ILMN): A Smart Investment or a Value Trap? An In-Depth Exploration

    Illumina (ILMN): A Smart Investment or a Value Trap? An In-Depth Exploration

    on GuruFocus.com

    Tech Stocks Soar, Microsoft Reaches Record High As AI Rally Resumes: What's Driving Markets Friday?

    on Benzinga.com

    Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    on Benzinga.com

    Why Illumina Inc Stock Is Falling

    on Benzinga.com

    12 Health Care Stocks Moving In Friday's Pre-Market Session

    on Benzinga.com

    Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday

    on Benzinga.com

    Illumina (ILMN) Q3 Earnings Surpass Estimates, '23 View Cut

    on Zacks.com

    Unity Software, Groupon, Trade Desk And Other Big Stocks Moving Lower In Friday's Pre-Market Session

    on Benzinga.com

    Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

    on Zacks.com

    Traders Hold Breath For Powell's Remarks, Bitcoin's Wild Ride Unleashed: What's Driving Markets Thursday?

    on Benzinga.com

    6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%

    on InvestorPlace.com

    Seeking Clues to Illumina (ILMN) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

    on Zacks.com

    Jim Cramer Highlights Key Earnings To Watch In The Energy Sector This Coming Week: 'Bullish Herd To Continue To Thunder'

    on Benzinga.com

    Earnings Preview: Illumina (ILMN) Q3 Earnings Expected to Decline

    on Zacks.com

    Illumina Unusual Options Activity

    on Benzinga.com

    10 Health Care Stocks With Whale Alerts In Today's Session

    on Benzinga.com

    LGND vs. ILMN: Which Stock Is the Better Value Option?

    on Zacks.com

    7 F-Rated Stocks to Sell Before November

    on InvestorPlace.com

    Is the Options Market Predicting a Spike in Illumina (ILMN) Stock?

    on Zacks.com

    Here’s Why Illumina Stock (NASDAQ:ILMN) Hit a 52-Week Low

    on TipRanks.com

    Illumina Inc.

    Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

    Competitors

    Name Chg % Market Cap
    Laboratory Corp. of America Holdings 0.24% $17.39B
    Charles River Laboratories International Inc. 1.49% $8.82B
    Quest Diagnostics Inc. 0.90% $14.93B
    10x Genomics Inc. -2.74% $4.19B
    Incyte Corp. -0.15% $11.75B
    Pacific Biosciences of California Inc. 0.00% $1.74B
    BGI Genomics Co. Ltd. -0.73% ¥20.53B
    Exelixis Inc. -0.10% $6.53B
    Invitae Corp. 11.85% $134.62M